AXICHEM AB | Sales 2022 | 5.01M 473K 647K | Sales 2023 | 1.81M 171K 234K | Capitalization | 86.2M 8.14M 11.13M |
|---|---|---|---|---|---|
| Net income 2022 | -17M -1.6M -2.2M | Net income 2023 | -20M -1.89M -2.58M | EV / Sales 2022 | 48.2 x |
| Net Debt 2022 | 12.21M 1.15M 1.58M | Net Debt 2023 | 5.96M 562K 770K | EV / Sales 2023 | 50.9 x |
| P/E ratio 2022 |
-13.3
x | P/E ratio 2023 |
-3.89
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 79.77% |
More Fundamentals
* Assessed data
More news
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
| Founder | 67 | 07-07-05 | |
Erik Lager
CTO | Chief Tech/Sci/R&D Officer | 49 | 19-03-31 |
Gunilla Savring
BRD | Director/Board Member | 62 | 13-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Founder | 67 | 07-07-05 | |
| Chairman | 78 | 16-12-31 | |
Gunilla Savring
BRD | Director/Board Member | 62 | 13-12-31 |
aXichem AB (publ) is a Sweden-based biochemical company. It develops an eco-friendly solution, Phenylcapsaicin. Phenylcapsaicin is a non-toxic antifouling agent, which can be used in the shipping industry, as it keeps vessels free from fouling. Additionally, the Company holds several world patents for alternative uses and applications of phenylcapsaicin. Phenylcapsaicin can be applied as bio-repellent against all living organisms in settings where animals cause damage to human installations. The Companyâs products comprise bio-repellents, feed ingredients, food and dietary supplements, which contain synthetically produced and patented capsaicin, traded as aXiphen. The Companyâs shareholders are MANAKIN LTD, BLACK ARROW LTD and LMK VENTURES AB, among others.
Sector
Specialty Chemicals
Calendar
2024-08-26
- Q2 2024 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| -17.44% | 3.63B | |
| +12.25% | 1.8B | |
| -20.92% | 563M | |
| -30.65% | 371M | |
| -81.65% | 216M | |
| -12.48% | 113M |
